Business Group Status Disclosure – Routine Report on Governance and Financials, No Immediate Impact on Shareholder Value


  • Carelabs, part of the Wonik group, reports strong financial health with individual assets of 83.96B KRW, liabilities of 7.71B KRW, equity of 76.25B KRW, and a debt ratio of 10.12%.
  • Sales of 33.82B KRW, operating loss of 5.67B KRW, net profit of 23.95B KRW driven by other income.
  • Top shareholder is Wonik Holdings (31.77%), total related party stake at 31.87%, maintaining stable governance.
  • Transactions with affiliates: goods/services of 1.32B KRW, other asset (land) sales of 59.63B KRW for asset reallocation.
  • Subsidiaries held: Good Doc (88.74%), Babitok (98.75%), IDB (51.00%) – controlling stakes.
  • Introduction of electronic voting; general shareholder voting rate is low at 0.50% but improving shareholder rights.
  • [AI Comprehensive Analysis]This is a routine status disclosure with no new capital raising or major equity changes, so limited direct stock impact. However, subsidiary acquisitions and large intercompany asset sales warrant monitoring for mid-to-long-term effects on profitability and financial structure.

KOSDAQ Filing Information


  • Filing: Large Enterprise Group Status Disclosure [Annual And First Quarter Use (Individual Company)]
  • Company: Carelabs (263700)
  • Submission: Carelabs Co.,Ltd
  • Receipt: 05-29-2026
  • Under Fair Trade Commission (KFTC)